淋巴结比率作为口腔舌鳞状细胞癌的预后标志物:一项队列研究。

Lymph node ratio as a prognostic marker of oral tongue squamous cell carcinoma: a cohort study.

作者信息

Iftikhar H, Rozi S, Zahid N, Awan M S, Nathani K R

机构信息

Aga Khan University Hospital, Karachi, Pakistan.

出版信息

Ann R Coll Surg Engl. 2020 Nov;102(9):726-732. doi: 10.1308/rcsann.2020.0173. Epub 2020 Aug 18.

Abstract

INTRODUCTION

Lymph node metastasis is a poor prognostic indicator and is well established in tongue squamous cell carcinoma. Based on the current staging system, accurate risk stratification is difficult. There is thus a need to evaluate an alternate method for predicting recurrence and survival. The objective of the study was to evaluate lymph node ratio as a prognostic marker as compared with N-staging for tongue squamous cell carcinoma.

MATERIALS AND METHODS

We conducted a retrospective cohort study with 56 patients with a lymph node ratio greater than 0.012 (exposed) and 74 patients with a lymph node ratio less than 0.012 (unexposed). Overall five-year survival and disease-free survival were assessed. The Cox proportional hazard model was used to analyse lymph node ratio as a predictor of outcome, together with other covariates.

RESULTS

A total of 130 patients were included in the study. Patients with lymph node ratio greater than 0.012 had a poor overall five-year (mean survival time 52.1 months vs 38.1 months) and disease-free survival (mean survival time 53.6 months vs 39.2 months). The hazard of death among patients with a lymph node ratio greater than 0.012 was 3.24 times higher than the hazard of death among patients with a lymph node ratio less than 0.012 (95% confidence interval 1.82-5.77).

DISCUSSION

Lymph node ratio is a superior prognostic marker compared with the currently used American Joint Committee on Cancer N-staging. Our findings also suggest that the margin status (involved) of the primary tumour resection adversely affects prognosis.

摘要

引言

淋巴结转移是预后不良的指标,在舌鳞状细胞癌中已得到充分证实。基于当前的分期系统,准确的风险分层较为困难。因此,需要评估一种预测复发和生存的替代方法。本研究的目的是评估淋巴结比率作为舌鳞状细胞癌预后标志物与N分期相比的情况。

材料与方法

我们进行了一项回顾性队列研究,其中56例患者淋巴结比率大于0.012(暴露组),74例患者淋巴结比率小于0.012(非暴露组)。评估了总体五年生存率和无病生存率。使用Cox比例风险模型分析淋巴结比率作为预后指标以及其他协变量。

结果

本研究共纳入130例患者。淋巴结比率大于0.012的患者总体五年生存率(平均生存时间52.1个月对38.1个月)和无病生存率(平均生存时间53.6个月对39.2个月)较差。淋巴结比率大于0.012的患者死亡风险比淋巴结比率小于0.012的患者高3.24倍(95%置信区间1.82 - 5.77)。

讨论

与目前使用 的美国癌症联合委员会N分期相比,淋巴结比率是一个更好的预后标志物。我们的研究结果还表明,原发肿瘤切除的切缘状态(受累)对预后有不利影响。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索